SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-048786
Filing Date
2024-04-26
Accepted
2024-04-26 12:28:22
Documents
15
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A agen-20240426.htm   iXBRL DEF 14A 1532888
2 GRAPHIC img190526726_0.jpg GRAPHIC 161006
3 GRAPHIC img190526726_1.jpg GRAPHIC 133389
4 GRAPHIC img190526726_2.jpg GRAPHIC 88372
5 GRAPHIC img190526726_3.jpg GRAPHIC 65887
  Complete submission text file 0000950170-24-048786.txt   3514850

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT agen-20240426.xsd EX-101.SCH 28080
18 EXTRACTED XBRL INSTANCE DOCUMENT agen-20240426_htm.xml XML 348016
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-29089 | Film No.: 24880817
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)